Page last updated: 2024-12-05

2,7-dihydroxynaphthalene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

2,7-Dihydroxynaphthalene, also known as 2,7-naphthalenediol, is a polycyclic aromatic compound with two hydroxyl groups at positions 2 and 7. It is a white to pale yellow solid with a melting point around 225°C. It is primarily synthesized through the sulfonation of naphthalene followed by alkaline fusion. 2,7-Dihydroxynaphthalene exhibits fluorescence and has been explored for its potential in various applications. It has been studied as a starting material for the synthesis of dyes, polymers, and pharmaceuticals. Its fluorescence properties have led to investigations in applications such as chemosensors and organic light-emitting diodes (OLEDs). Furthermore, 2,7-dihydroxynaphthalene has shown antimicrobial activity, particularly against bacteria and fungi, making it a potential candidate for further development as an antimicrobial agent. The compound's intriguing properties and diverse applications continue to drive research interest in understanding its chemical behavior and exploring its potential in different fields.'

Cross-References

ID SourceID
PubMed CID11397
CHEMBL ID205165
SCHEMBL ID29711
MeSH IDM0280636

Synonyms (55)

Synonym
naphthalenediol-2,7
4-06-00-06570 (beilstein handbook reference)
0to8e448ud ,
unii-0to8e448ud
2,7-naphthalenediol (8ci,9ci)
nsc 407541
naphthalenediol-2,7 [french]
einecs 209-478-7
brn 2042383
naphthalene-2,7-diol
582-17-2
2,7-naphthalenediol
c.i. 76645
nsc407541
2,7-dihydroxynaphthalene ,
nsc-407541
ci 76645
2,7-dihydroxynaphthalene, 97%
D0594
CHEMBL205165
AKOS000120354
STK164520
A8253
FT-0610749
2,7-dihydroxy naphthalene
2,7-dihydroxy-naphthalene
2,7-naphthalene diol
naphthalene-2-7-diol
2,7-dihydorxynaphthalene
bdbm36286
2,7-dihdroxynaphthalene
SCHEMBL29711
ci-76645
2,7-naphthalenediol [inci]
c.i.-76645
DTXSID2060387
naphthalenediol-(2,7)
W-105406
AC-24462
mfcd00004085
2,7-dihydroxyl naphthalene
GEO-03800
2,7-dihydroxynaphthalene, 99.0%
SY006498
F1995-0184
EN300-21321
2,7-naphthalindiol
AS-12661
2-hydroxy-7-naphthol
D71102
Q27237248
2,7-naphthalenediol; 2,7-naphthohydroquinone; 7-hydroxy-2-naphthol; c.i. 76645; nsc 407541
ZB1380
CS-W016167
Z104495344
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID365329Ratio of Kcat to Km of Streptomyces coelicolor A3(2) prenyltransferase assessed as formation of 1-(3,7-dimethylocta-2,6-dienyl)naphthalene-2,7-diol2008Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17
Chemoenzymatic syntheses of prenylated aromatic small molecules using Streptomyces prenyltransferases with relaxed substrate specificities.
AID365144Activity for Streptomyces coelicolor A3(2) prenyltransferase assessed as formation of 1-(3,7-dimethylocta-2,6-dienyl)naphthalene-2,7-diol2008Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17
Chemoenzymatic syntheses of prenylated aromatic small molecules using Streptomyces prenyltransferases with relaxed substrate specificities.
AID1390972Uncompetitive inhibition of Mycobacterium tuberculosis IMPDH deltaCBS mutant assessed as reduction in NADH production preincubated for 5 mins followed by substrate IMP addition at increasing concentration measured for 32 mins in presence of constant conce2018Journal of medicinal chemistry, 04-12, Volume: 61, Issue:7
Fragment-Based Approach to Targeting Inosine-5'-monophosphate Dehydrogenase (IMPDH) from Mycobacterium tuberculosis.
AID1390975Inhibition of Mycobacterium tuberculosis IMPDH deltaCBS mutant assessed as reduction in NADH production at 1 mM using IMP as substrate preincubated for 5 mins followed by substrate addition measured for 32 mins in presence of NAD+2018Journal of medicinal chemistry, 04-12, Volume: 61, Issue:7
Fragment-Based Approach to Targeting Inosine-5'-monophosphate Dehydrogenase (IMPDH) from Mycobacterium tuberculosis.
AID261690Antiproliferative activity against human fibroblast HFL1 cells2006Journal of medicinal chemistry, Mar-23, Volume: 49, Issue:6
Selective antiproliferative activity of hydroxynaphthyl-beta-D-xylosides.
AID1390970Inhibition of Mycobacterium tuberculosis IMPDH deltaCBS mutant assessed as reduction in NADH production using IMP as substrate preincubated for 5 mins followed by substrate addition measured for 32 mins in presence of NAD+2018Journal of medicinal chemistry, 04-12, Volume: 61, Issue:7
Fragment-Based Approach to Targeting Inosine-5'-monophosphate Dehydrogenase (IMPDH) from Mycobacterium tuberculosis.
AID1059430Inhibition of recombinant human IDO1 expressed in Escherichia coli EC538 using L-tryptophan as substrate at 1 mM after 1 hr relative to control2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).
AID261691Antiproliferative activity against human bladder carcinoma T24 cells2006Journal of medicinal chemistry, Mar-23, Volume: 49, Issue:6
Selective antiproliferative activity of hydroxynaphthyl-beta-D-xylosides.
AID1390973Uncompetitive inhibition of Mycobacterium tuberculosis IMPDH deltaCBS mutant assessed as reduction in NADH production preincubated for 5 mins followed by substrate IMP addition at a constant concentration measured for 32 mins in presence of increasing con2018Journal of medicinal chemistry, 04-12, Volume: 61, Issue:7
Fragment-Based Approach to Targeting Inosine-5'-monophosphate Dehydrogenase (IMPDH) from Mycobacterium tuberculosis.
AID1267460Inhibition of recombinant N-terminal truncated human cytosolic 5'-nucleotidase-2 assessed as inhibition of inosine 5'-monophosphate hydrolysis at 1 mM by rapid green malachite assay2015Journal of medicinal chemistry, Dec-24, Volume: 58, Issue:24
Identification of Noncompetitive Inhibitors of Cytosolic 5'-Nucleotidase II Using a Fragment-Based Approach.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (12.50)18.2507
2000's6 (37.50)29.6817
2010's7 (43.75)24.3611
2020's1 (6.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.14

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.14 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.71 (4.65)
Search Engine Demand Index45.47 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (37.14)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (6.25%)4.05%
Observational0 (0.00%)0.25%
Other15 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]